This year's government work report has listed biomedicine as an emerging pillar industry for the first time! "During the meeting, Zhao Hong, a member of the National Committee of the Chinese People's Political Consultative Conference and deputy director of the Hepatobiliary Surgery Department at the Cancer Hospital of the Chinese Academy of Medical Sciences, couldn't help but share this exciting news with the committee members and reporters around him. Excitement stems from a long-term focus on the research and application of innovative drugs. Zhao Hong, who holds multiple roles such as clinical doctor, director of a key laboratory in Beijing, and head of clinical research for multiple new drug launches, is well aware of the difficulty of "medicine". The difficulty lies in the huge investment and lengthy research and development. From the laboratory to the market, an innovative drug represents both a breakthrough from 0 to 1 and a leap to elongate 1. The dual difficulty lies in the fact that the launch of innovative drugs is far from the end. How to make more patients use it, gain recognition from more countries, and clarify the indications is a challenge worldwide. From the clinic to the laboratory, from the pharmaceutical company to the biopharmaceutical base, Zhao Hong has been walking steadily in the past year. He takes note of the voices and opinions of patients, researchers, and pharmaceutical company leaders, turning them into weighty suggestions and reflections. Members of the Chinese People's Political Consultative Conference must perform their duties well by conducting extensive investigations and in-depth research in familiar fields, adhering to a problem awareness, and turning the results of frontline research into scientifically feasible suggestions. ”Zhao Hong said, "The relevant deployment in the government work report demonstrates China's strong support attitude towards the development of innovative drugs. What we should do is to provide suggestions and recommendations to further bridge the 'last mile' between drugs and patients, benefit patients, and empower the industry." Zhao Hong issued a series of suggestions on how to make hospitals have the motivation to create new drugs? We can improve the cost compensation mechanism for innovative drugs and allow the collection of pharmaceutical service fees for some innovative drug pilot projects. How to give patients confidence in using innovative drugs? While encouraging more innovative drugs to enter the national medical insurance catalog through negotiations, a diversified collaborative payment system of "medical insurance+commercial insurance" can be established. How to incentivize pharmaceutical companies to produce innovative drugs? We can make regular adjustments to the value-added tax preferential policies for anti-cancer drugs and rare disease drugs that have already been introduced, and accelerate the inclusion of innovative anti-cancer drugs in the scope of tax incentives. According to statistics, during the 14th Five Year Plan period, China approved 230 innovative drugs for market launch. The number of new drugs under development accounts for about 30% of the global total. For ordinary people, the need for medical treatment is very simple, which is to use good and cheap medicines. ”Zhao Hong said that currently, China has made significant progress in this area. Currently, China ranks among the top in the world in terms of the number of new drugs under development and the number of clinical trials. ”Zhao Hong proudly said. Open the draft outline of the 15th Five Year Plan, which mentions "innovative drugs" seven times and clearly deploys "improving the mechanism of medical insurance supporting the high-quality development of innovative drugs and medical devices, perfecting the catalog of innovative drugs, and encouraging commercial insurance to expand the payment scope of innovative drugs". We are fortunate to have caught up with a good time for the development of innovative drugs in China. ”Zhao Hong smiled and said, "The 'last mile' will definitely become more and more smooth!" (News Agency)